logo-loader
viewTekcapital PLC

Tekcapital’s Salarius to launch SaltMe! snack product across 71 stores

The new range of crisps uses Salarius' MicroSalt low-sodium particles for flavouring

Tekcapital PLC - Tekcapital’s Salarius to launch SaltMe! snack product across 71 stores

Tekcapital PLC’s (LON:TEK) portfolio firm, Salarius, has received an order from its distribution partner to launch its SaltMe! Range of low-sodium snack products across 71 stores in May.

The launch of the crisp range represented “an important milestone for SaltMe!”, the investment firm said on Tuesday, adding that “thousands of customers” will now be able to buy the new crisp range, which uses Salarius’ MicroSalt particles for flavouring.

READ: Tekcapital says new US policy “potentially relevant” for portfolio firm Belluscura

"We are very excited to execute this program that will put this new and fantastic brand in front of thousands of consumers quickly. In a world where taste is everything, we feel optimistic that SaltMe! snacks will engender strong loyalty and repurchase from our new customers”, said Salarius chief executive Victor Hugo Manzanilla.

As of February 2020, Tekcapital holds a 91.7% stake in Salarius.

The shares were up 2.2% at 7.7p in early trading on Tuesday.

--Adds share price--

Quick facts: Tekcapital PLC

Price: 16.25 GBX

LSE:TEK
Market: LSE
Market Cap: £14.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tekcapital PLC named herein, including the promotion by the Company of Tekcapital PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Canntab Therapeutics gets first commercial sale with Medipharm

Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein and Special Advisor Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has signed their first contract for their slow release tablets with MediPharm.  Goldstein discusses how the...

8 hours, 20 minutes ago

2 min read